Position in ICCC
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$40,200
+$14,880 QoQ
Shares Held
4,000
0.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 30 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HM PAYSON & CO holds $1,342,005 across 18 Biotechnology names. ICCC ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,052 | $1,019,289 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
2,320 | $126,532 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105 | $65,471 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
1,700 | $52,411 | |
| 5 | ICCC |
Immucell Corp /De/
This page
|
4,000 | $40,200 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
50 | $9,364 | |
| 7 | DBVT |
DBV Technologies S.A.
|
420 | $6,888 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
600 | $5,874 |
All Filings in ICCC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,200 | 4,000 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $25,320 | 4,000 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $24,600 | 4,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $25,000 | 4,000 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $27,840 | 4,000 | Shares | Sole | 2025-10-17 | |
| 2025-03-31 | $19,160 | 4,000 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $20,600 | 4,000 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $14,520 | 4,000 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $29,100 | 6,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $31,800 | 6,000 | Shares | Sole | 2024-06-20 | |
| 2023-12-31 | $30,540 | 6,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $32,040 | 6,000 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $60,650 | 12,130 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $41,950 | 8,130 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $49,593 | 8,130 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $60,812 | 8,130 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $70,649 | 8,130 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $78,454 | 8,130 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $65,040 | 8,130 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $18,720 | 2,000 | Shares | Sole | 2021-11-30 | |
| 2021-06-30 | $19,000 | 2,000 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $19,280 | 2,000 | Shares | Sole | 2021-06-15 | |
| 2020-12-31 | $121,975 | 20,500 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $160,185 | 29,500 | Shares | Sole | 2020-12-21 | |
| 2020-06-30 | $139,535 | 29,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $96,645 | 25,500 | Shares | Sole | 2020-07-01 | |
| No filing history on record for this holder in this stock. | ||||||